Arcadia Q1 revenue $3.22M (+289% YoY), net loss $4.49M; GoodWheat launch, HB4 milestone

Arcadia Biosciences, Inc.

2022-Q1 EPS reported -$0.20 revenue$3,220,000

Q1 revenue $3.22M (+289% YoY); net loss $4.49M (vs. $2.06M income YoY on prior-year Bioceres gain)
Operating loss improved to $4.62M from $5.33M YoY; sales up 48% sequentially from Q4 2021
First retail orders of GoodWheat pasta shipped; Amazon e-commerce launch expected June 2022
HB4 soybeans approved in China; $2M milestone payment triggered and 6% royalties on future Bioceres revenue

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.